<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cat cortical arterioles and venules were exposed in vivo to the <z:chebi fb="0" ids="29108">Ca2+</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:chebi fb="1" ids="7565">nifedipine</z:chebi> under <z:mpath ids='MPATH_458'>normal</z:mpath> conditions and in focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Topical application of <z:chebi fb="1" ids="7565">nifedipine</z:chebi> caused a marked, concentration-dependent arteriolar <z:mpath ids='MPATH_66'>dilatation</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The dilatatory responses increased significantly with decreasing arteriolar size </plain></SENT>
<SENT sid="3" pm="."><plain>Perivenular microapplication of <z:chebi fb="1" ids="7565">nifedipine</z:chebi> invariably caused <z:mpath ids='MPATH_66'>dilatation</z:mpath> that was less pronounced but more long-lasting than that on the arteriolar side </plain></SENT>
<SENT sid="4" pm="."><plain>Arterioles, which constricted after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, invariably dilated following <z:chebi fb="1" ids="7565">nifedipine</z:chebi> application </plain></SENT>
<SENT sid="5" pm="."><plain>These dilatatory responses were transient but could be repeated, and on some occasions were accompanied by a return of flow in vessels in which stasis had been present </plain></SENT>
<SENT sid="6" pm="."><plain>The results suggest that <z:chebi fb="1" ids="7565">nifedipine</z:chebi> is able to dilate cerebral vessels both under <z:mpath ids='MPATH_458'>normal</z:mpath> conditions and when contracted during focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>